Featured Events

2019 Annual Meeting of Stockholders

Dec 6, 2019 • 10:00am PST

46th Annual VEITH Vascular Symposium

Nov 19 – Nov 23, 2019

View All Events

Latest Financial Results

Q3 2019

Quarter Ended Sep 30, 2019

Latest Annual Filing

Fiscal Year Ended Dec 31, 2018

View Filing

Stock Information

Company Overview

HJLI specializes in developing and manufacturing bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two product candidates: the porcine tissue based VenoValve®, which is intended to be surgically implanted in the deep venous system of the leg to treat Chronic Venue Insufficiency and the CoreoGraft®, a bovine tissue based off the shelf conduit intended to be used for coronary artery bypass surgery.

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Hancock Jaffe Laboratories, Inc.
70 Doppler
Irvine, CA 92618
T: 949-261-2900
F: 949-261-2992

Investor Relations

MZ North America
Chris Tyson
Managing Director
T: 949-491-8235
HJLI@mzgroup.us

Transfer Agent

V Stock Transfer LLC